Literature DB >> 10609494

The prognostic value of peritoneal cytology in ovarian cancer.

M Simojoki1, M Santala, S Vuopala, A Kauppila.   

Abstract

We studied the significance of peritoneal cytology as a prognostic factor in primary epithelial ovarian cancer. Intraperitoneal specimens for cytological examination were taken from 73 patients at primary operation for ovarian cancer. The prognostic value of cytological findings was analyzed by the Kaplan-Meier method. It was also correlated to clinical stage, tumor histology, histopathological grade, residual tumor, presence of ascites and age by using the chi2-test. The value of cytology in relation to other factors was assessed by Cox-multivariate analysis. In univariate analysis peritoneal cytological findings correlated significantly to survival. In Cox-multivariate analysis peritoneal cytology, histopathological grade and the age of the patient were found to be significant independent prognostic factors in epithelial ovarian cancer. According to this data peritoneal cytology can be considered as an important prognostic factor in ovarian cancer. Therefore it should be evaluated routinely in association with surgery of ovarian tumors.

Entities:  

Mesh:

Year:  1999        PMID: 10609494

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  6 in total

1.  How valuable is ascitic cytology in the detection and management of malignancy?

Authors:  R O S Karoo; T D R Lloyd; G Garcea; H D Redway; G S R Robertson
Journal:  Postgrad Med J       Date:  2003-05       Impact factor: 2.401

2.  Role of peritoneal lavage cytology and prediction of prognosis and peritoneal recurrence after curative surgery for colorectal cancer.

Authors:  Sung Joon Bae; Ui Sup Shin; Young-Jun Ki; Sang Sik Cho; Sun Mi Moon; Sun Hoo Park
Journal:  Ann Coloproctol       Date:  2014-12-31

Review 3.  Prognostic significance of positive peritoneal cytology in resectable pancreatic cancer: a systemic review and meta-analysis.

Authors:  Feng Cao; Jia Li; Ang Li; Fei Li
Journal:  Oncotarget       Date:  2017-02-28

Review 4.  Epigenetic biomarkers of promoter DNA methylation in the new era of cancer treatment.

Authors:  Keishi Yamashita; Kei Hosoda; Nobuyuki Nishizawa; Hiroshi Katoh; Masahiko Watanabe
Journal:  Cancer Sci       Date:  2018-10-26       Impact factor: 6.716

5.  Role of primary surgery in advanced ovarian cancer.

Authors:  Karsten Münstedt; Folker E Franke
Journal:  World J Surg Oncol       Date:  2004-10-02       Impact factor: 2.754

6.  Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant, and malignant ascites.

Authors:  Maria Jung; Svenja Pützer; Heidrun Gevensleben; Sebastian Meller; Glen Kristiansen; Dimo Dietrich
Journal:  Clin Epigenetics       Date:  2016-03-01       Impact factor: 6.551

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.